INBX

Inhibrx Biosciences Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↓ 0/10
  • Momentum↑ 9/10
Inhibrx Biosciences sales and earnings growth
INBX Growth
Low
  • Revenue Y/Y↓ -19.26%
  • EPS Y/Y↓ -110.76%
  • FCF Y/Y↑ 32.83%
Inhibrx Biosciences gross and profit margin trends
INBX Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -11077.60%
  • ROIC↓ -213.90%
Inhibrx Biosciences net debt vs free cash flow
INBX Risk
Great
  • Debt / Equity↑ 2.9
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -16.2

Inhibrx Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗